| Award PI Last Name |
Award Sponsor Name |
Project Title |
| COTMAN |
PHS - NIH Inst on Aging |
Alzheimer's Disease Research Center of the University of California Irvine |
| |
Univ of WA |
National Alzheimer's Coordinating Center (NACC) Participant |
| |
PHS - NIH Inst on Aging |
Brain Aging and Gene Expression Patterns Using Microarrays |
| |
State of CA - H&W, Misc Agencies |
Alzheimer's Disease Research Center at The University of California Irvine |
| |
The effort on this project is focused on clinical evaluation and characterization of research subjects in the ADRC. |
| |
| CRAMER |
STEM CELL THERAPEUTICS CORP. (CANADA) |
Safety of Beta-Hcg + Erythropoeitin in Acute Stroke |
| |
NORTHSTAR NEUROSCIENCE, INC (FRMLY VERTIS NEUROSCIENCE) |
Analysis of MRI Data From a Restorative Stroke Trial |
| |
Rehabilitation Inst of Chicago |
Engineering for Neurologic Rehabilitation |
| |
University of Florida |
BDNF Genotype, Cortical Plasticity and Recovery from Stroke |
| |
| CRIBBS |
PHS - NIH Neurological Disorders & Stroke |
Combining AD Epitope Vaccine with Innate Immunity |
| |
PHS-NIH Inst on Aging |
Multiple Approaches to Abeta Vaccination in Animal Models |
| |
American Health Assistance Fdn |
CNS Delivery of Immunotherapy Using MSCs |
| |
UC Mexus |
Selection of Potentially Therapeutic Single Chain Antibodies Directed Against N-Truncated Forms of Amyloid-Beta Peptide |
| |
Centocor, A Johnson & Johnson Company |
Investigation of the Effect of Anti-Beta-Amyloid Antibodies on Cognitive Behavior in the 3xTg-AD Mouse Model of Alzheimer's Disease |
| |
| DEMETRIOU |
National Multiple Sclerosis Soc |
Regulation of Spontaneous Autoimmune Demyelinating Disease by Mgat5 N-Glycns |
| |
|
| FISHER |
PHS - NIH Neurological Disorders & Stroke |
Hemorheological Factors in Cerebral Ischemia |
| |
Boehringer Ingelheim |
Effects Of Telmisartan (Micardis) and/or Dipyridamole On Brain Microvasulature In Vitro |
| |
| HERMANOWICZ |
Teva Neuroscience Inc. |
A Multicenter, Double-Blind, Randomized Start, Placebo-Controlled, Parallel-Group Study to Assess Rasagiline as a Disease Modifying Therapy in Early Parkinson's Disease Subjects |
| |
Valeant Pharmaceuticals Intl |
A to Z (Agonist to Zelapar) |
| |
Allergan Inc |
A Multicenter Study Evaluating The Efficacy And Safety Of Botox (Botulinum Toxin Type A) Purified Neurotoxin Complex As a Headache Prophylaxis In Migraine Patients With 15 Or More Headache Days Per 4-Week Period In A 24-Week, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Phase Followed By A 32-Week Open Label Extension Phase |
| |
Allergan Inc |
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Single Treatment Cycle, Parallel Evaluation of the Safety, Efficacy and Immunogenicity of Two Formulations of BOTOX (Botulinum Toxin Type A) Purified Neurotoxin Complex (Formulation Nos. 9060X and 9525X), Followed by a Blinded Active Treatment Extnension of up to Two Additional Treatment Cycles in Patients with Cervical Dystonia |
| |
Kyowa Pharmaceuticals Inc |
An Open-Label, Multicenter, Study of The Continued Safety of Istradefylline In Subjects With Parkinson's Disease Who Have Recently Completed One Year Of Treatment With Istradefylline |
| |
Quintiles Transnatl Inc. |
A Multi-Center, Randomized, Double Blind, Placebo-Controlled, Parallel Group Study of the Efficacy, Safety and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients with Motor Fluctuations |
| |
Quintiles |
A Multi-centre, Open Label Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of E2007 as an Adjunctive Therapy in Levodopa Treated Parkinson's Disease Patients with Motor Fluctuations |
| |
Inc Research, Inc (Raleigh, North Carolina) |
A Multi-Center, Placebo-Controlled, Double-Blind Trial to Examine the Safety & Efficacy of ACP-103 in the Treatment of Psychosis in Parkinson's Disease |
| |
Inc Research, Inc (Raleigh, North Carolina) |
Prospective, Double-Blind, Placebo-Controlled, Randomized, Multi-Center Trial With a Double-Blind Parallel-Group Extension Period to Investigate the Efficacy and Safety of Different Doses of NT 201 in the Treatment of Cervical Dystonia. |
| |
Novartis AG |
A Prospective, Multi-Center, Randomized, Open-Label Study with Blinded Raters to Evaluate the Effects of Immediate Versus Delayed Switch to Stalevo on Motor Function and Quality of Life in Patients with Parkinson's Diseases with End-of-Dose Wearing Off |
| |
| KAWAS |
NIA/NIH |
Clinical and Pathological Studies in the Oldest Old - The 90+ Study |
| |
NIA/NIH |
Alzheimer's Disease Research Center of UCI - Clinical evaluation and characterization of research subjects in the ADRC |
| |
NCCAM/NIH |
Ginkgo Biloba Prevention Trial in Older Individuals (GEM Study) |
| |
NIA/NIH |
Leukocyte-Derived Biomarkers as Predictors of Risk Progression in AD |
| |
| MOZAFFAR |
Univ of AL at Birmingham |
Thymectomy in Non-Thymomatous MG Patients on Prednisone |
| |
Insmed Inc |
A Placebo controlled, Randomized, Double-Blind Phase II Clinical Trial to Evaluate Tolerability, Safety and Efficacy Endpoints after Administration of Recombinant Human Insulin-Like Growth Factor-I/Recombinant Human Insulin-Like Growth Factor Binding Protein-3 (rhIGFBP-3) for 24 Weeks in Adults with Myotonic Dystrophy Type I |
| |
Phoenix Neurological Associates, Ltd |
Database of Immune-Mediated Neuropathy Treatment Outcomes |
| |
| SCHREIBER |
Alzheimer's Assc |
Efficacy of Nicotinamide for the Treatment of Alzheimer's Disease |
| |
| STARR |
PHS-NIH Deafness & Other Communication Disorders |
Hearing Deficit Due to Auditory Neuropathy |
| |
| WEISS |
PHS-NIH Neurological Disorders & Stroke |
AMPA/Kainate Receptors, Free Radicals and Motor Neuron injury |
| |
